Top medtech conferences in 2026

The Latest

• 

  Edwards wins FDA clearance for LAA clip, setting up competition with AtriCure and Medtronic

  Edwards Lifesciences is expected to introduce the new device to surgical heart valve customers this year in a “measured, targeted rollout,” one analyst said.

  FDA

• 

  J&J starts pivotal trials of Shockwave IVL device in carotid arteries

  J&J is working to expand use of Shockwave’s technology as competition in intravascular lithotripsy builds from companies like Boston Scientific and Stryker.

  Cardiac

• 

  Aidoc wins breakthrough nod for AI that reads chest X-rays

  Aidoc is working on an artificial intelligence feature that would analyze chest X-rays and generate preliminary reports for more than 100 findings.

  FDA

• 

  Q&A

  BD’s Bilal Muhsin talks AI in connected care

  Muhsin discussed how BD is rolling out a new medication dispenser and a software platform that pulls together data from the company’s various devices.

  Updated June 25, 2026

  AI

• 

  Agilent finalizes Biocare Medical takeover

  The acquisition strengthens Agilent’s presence in areas including cancer and infectious disease diagnostic and research markets.

  M&A

• 

  Labcorp rolls out colorectal cancer screening test nationwide

  The Geneoscopy test competes with Exact Sciences’ Cologuard for the U.S. colorectal cancer screening market.

  Diagnostics

• 

  Tissium secures up to $68M to back rollout of nerve repair platform

  The MIT spinout will use the financing, from investors and the European Investment Bank, to accelerate the U.S. launch of its Coaptium sutureless nerve repair technology.

  Medical Devices

• 

  FDA drops Whoop warning letter over blood pressure feature

  Whoop made changes to its blood pressure insights feature that satisfied the FDA’s requirements for wellness devices.

  FDA

• 

  US health spending spikes to $5.7T in 2025, though growth should moderate, CMS finds

  Utilization — not cost growth — continues to accelerate spending, government actuaries said. Spiking prescription drug spending, including on GLP-1s, is especially acute.

• 

  MiniMed launches Abbott-made Instinct glucose sensor in Europe

  Overseas markets are central to MiniMed’s business, accounting for 70% of reported net sales in the company’s 2026 financial year.

  Diabetes

• 

  Karl Storz laying off employees in North Carolina amid robotics strategy shift

  The cuts come as Karl Storz plans to retire the Asensus brand and the Senhance robot as part of organizational changes.

  M&A

• 

  Medtronic appoints veteran J&J exec as first CFO of innovation

  Eric Lenard comes to the new position with more than two decades of experience in medtech finance, as Medtronic steps up its investment in innovation.

  Medical Devices

• 

  Insulet hires first chief R&D officer amid growing competition

  Divakar Ramakrishnan brings experience from Convatec and Eli Lilly. Insulet said the new hire was an important step in strengthening the company’s innovation capabilities.

  Diabetes

• 

  HHS, responding to China’s rise, moves to fast-track early drug research

  A series of newly planned reforms are designed to entice companies to start early trials in the U.S. rather than overseas.

  FDA

• 

  FDA posts early alert over device used with Impella heart pumps

  J&J’s Abiomed and manufacturing partner Oscor warned of a bleeding risk from devices used to introduce catheters to the body. 

  FDA

• 

  4 diabetes tech execs on the future of multi-analyte glucose sensors

  Executives with Abbott, PercuSense and Biolinq spoke with MedTech Dive about what’s next with multi-analyte sensor technology.

  Diabetes

• 

  Profile

  ‘Putting the body back together’ with MMI’s microsurgery robot

  MMI built a robot to help surgeons perform microsurgical procedures with more control than is possible with the human hand alone.

  Medical Devices

• 

  Zoll receives FDA warning letter over quality concerns

  The FDA cited problems with some of Zoll’s ventilators, automated external defibrillators and electrodes.

  Updated June 22, 2026

  FDA

• 

  Distalmotion, in US push, adds more robotic gynecology indications

  The Swiss robotic surgery company, which is rolling out its Dexter system in the U.S., said the new indications will help ASCs maximize use of the system.

  FDA

• 

  Penumbra wins CE mark for Thunderbolt clot removal tech

  The international launch could benefit from Boston Scientific’s global footprint when the company closes its takeover of Penumbra.

  Cardiac

• 

  FDA warns breast biopsy needle shortage to continue into 2027

  The shortage follows Hologic removing certain breast biopsy needles from the market in January.

  FDA

• 

  Medtech M&A maintains momentum following decade-high 2025: PwC

  Deal volumes and values are tracking above the first half of 2025, driven by Boston Scientific’s Penumbra buyout and Danaher’s Masimo acquisition.

  M&A

• 

  CMS proposes Medicare coverage expansion for TAVR

  The proposed Medicare coverage change could help Edwards Lifesciences gain market share from Medtronic and Boston Scientific, an analyst said.

  Cardiac

• 

  IRhythm discloses data stolen from third-party applications in cyberattack

  The cardiac monitoring company said that a threat actor has demanded payment in exchange for not publicly releasing the stolen data.

  Cybersecurity

• 

  J&J commits $1B to expand contact lens production in Florida

  The investment will add J&J’s manufacturing, packaging and distribution capabilities to meet growing demand for its contact lenses.

  Medical Devices

More stories